New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Enanta Pharmaceuticals, Inc. (ENTA) vs Vanda Pharmaceuticals Inc. (VNDA)
- Enanta Pharmaceuticals, Inc. ENTA 7.62 −4.51%
- Vanda Pharmaceuticals Inc. VNDA 3.45 −5.99%
Enanta Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Vanda Pharmaceuticals Inc. are of similar size ($235.2M and $232.7M). Vanda Pharmaceuticals Inc. grew revenue faster over the last twelve months: 8.11% against −3.56%. Enanta Pharmaceuticals, Inc. has the higher net margin (−108.3% vs −119.9%) and the higher return on invested capital (0.00% vs −180.2%). Across the 17 metrics below, Enanta Pharmaceuticals, Inc. leads on 9 and Vanda Pharmaceuticals Inc. on 8.
Valuation
Profitability
| Metric | ENTA | VNDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.59% | 70.18% |
| Operating margin | (99.01%) | (77.59%) | 0.00% |
| Net margin | (108.33%) | (119.87%) | 0.00% |
| Free cash flow margin | (67.88%) | — | 0.00% |
| Return on equity | (94.19%) | (82.55%) | (51.58%) |
| Return on assets | (24.54%) | (55.89%) | (45.91%) |
| Return on invested capital | 0.00% | (180.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack